Any person traveling to Kenya from Brunei, Czech Republic, Kuwait, Spain, Switzerland and Thailand will be expected to undergo a mandatory 14 days quarantine upon arrival in the country, at their own cost.
The notice issued by Kenya Civil Aviation Authority -KCAA stated that the requirement is effective from Monday, March 8.
“Travellers from the listed states and territories shall be required to undergo mandatory quarantine upon arrival into Kenya at their own cost. This is effective from Monday 8th March 2021,” the notice read.
The notice further stated that travelers shall be required to be in possession of a negative PCR-based Covid-19 test result conducted within 72 hours before travel and not display any flu-like symptoms upon arrival.
“Travelers must provide evidence of their booking for the quarantine locations 24hrs before boarding,” said KCAA.
Kenya on Sunday reported 465 new cases of Coronavirus bringing the total number of confirmed cases to 108,827.
The new cases are from a sample size of 5,691 that was tested in the last 24 hours.
Nairobi has 310 cases, Kiambu 54, Nakuru 28, Mombasa 11, Tharaka Nithi 11, Kajiado 10, Machakos 9, Busia 8, Kitui 7, Meru 3, Laikipia 3, Kilifi 3, Uasin Gishu 3, Kwale 1, Makueni 1, Marsabit 1, Murang’a 1 and Isiolo 1.
COVID-19 Vacine in Kenya
Kenya has rolled out the Covid-19 vaccine. The first batch arrived in Kenya last week on Tuesday and were kept at the Central Vaccines Warehouse in Kitengela.
Cabinet ratified the distribution framework for the vaccine; with first priority being given to healthcare workers, frontline workers including security personnel and teachers vulnerable persons and groups and the hospitality sector.
Kenya will be using the COVID-19 vaccine developed by Astrazeneca and Oxford University.
The Oxford vaccine is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees. It has been modified to look more like coronavirus – although it can’t cause illness.
Once injected, it teaches the body’s immune system how to fight the real virus, should it need to.
The recommended dosage is two doses given intramuscularly (0.5ml each) with an interval of 8 to 12 weeks.
The AZD1222 vaccine against COVID-19 has an efficacy of 63.09% against symptomatic SARS-CoV-2 infection.
The government plans to administer the vaccine for free.
Last Friday, Director General, Dr Patrick Amoth led the health workers in receiving the first Covid-19 jab, followed by the KNH Chief Executive Officer Dr Evans Kamuri and the Head of Immunization program Dr Collins Tabu.